Aktivitas Antiparkinson Ekstrak dan Fraksi Buah Kemukus (Piper cubeba L.) pada Tikus Putih Galur Sprague Dawley
Downloads
Downloads
Lee TK, Yankee EL. A review on Parkinson’s disease treatment. Neuroimmunol Neuroinflammation. 2021;8.
Moon HE, Paek SH. Mitochondrial Dysfunction in Parkinson’s Disease. Exp Neurobiol. 2015 Jun 30;24(2):103–16. doi: 10.5607/en.2015.24.2.103
Picca A, Calvani R, Coelho-Júnior HJ, Landi F, Bernabei R, Marzetti E. Mitochondrial dysfunction, oxidative stress, and neuroinflammation: Intertwined roads to neurodegeneration. Antioxidants. 2020;9(8):1–21. doi: 10.3390/antiox9080647
Liguori I, Russo G, Curcio F, Bulli G, Aran L, Della-Morte D, et al. Oxidative stress, aging, and diseases. Clin Interv Aging. 2018 Apr;13:757–72. doi: 10.2147/CIA.S158513
Park JS, Davis RL, Sue CM. Mitochondrial dysfunction in Parkinson’s disease: new mechanistic insights and therapeutic perspectives. Curr Neurol Neurosci Rep. 2018;18(5). doi: 10.1007/s11910-018-0829-3.
Iarkov A, Barreto GE, Grizzell JA, Echeverria V. Strategies for the treatment of Parkinson’s disease: beyond dopamine. Front Aging Neurosci. 2020;12(January):1–20. doi: 10.3389/fnagi.2020.00004
JelLinger KA. Parkinson’s disease. Pathobiology of human disease: a dynamic encyclopedia of disease mechanisms. Elsevier Inc.;2014.2021–35p.
Church FC. Treatment options for motor and non‐motor symptoms of parkinson’s disease. Biomolecules. 2021;11(4). doi: 10.3390/biom11040612
DeMaagd G, Philip A. Parkinson’s disease and its management: part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. P T. 2015 Aug;40(8):504–32.
Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA - J Am Med Assoc. 2020;323(6):548–60. doi: 10.1001/jama.2019.22360.
Gandhi KR, Saadabadi A. Levodopa (L-Dopa). StatPearls. Treasure Island (FL): StatPearls Publishing. 2021.
Banjarnahor SDS, Artanti N. Antioxidant properties of flavonoids. Med J Indones. 2014;23(4):239–44.
Jung UJ, Kim SR. Beneficial effects of flavonoids against Parkinson’s disease. J Med Food. 2018;21(5):421–32.
Makmun MT al, Widodo SE, Sunarto. Construing traditional javanese herbal medicine of headache: transliterating, translating, and interpreting serat primbon jampi Jawi. Procedia - Soc Behav Sci. 2014;134:238–45.
Nahak G, Sahu RK. Phytochemical evaluation and antioxidant activity of Piper cubeba and Piper nigrum. J Appl Pharm Sci. 2011;1(8):153–7.
Khalaf NA, Shakya AK, Al-Othman A, El-Agbar Z, Farah H. Antioxidant activity of some common plants. Turkish J Biol. 2008;32(1):51–5.
Ardhianta IR, Peranginangin JM, Handayani R. Antiparkinson activity of rosella extract (Hibiscus sabbdariffa L.) in white male (Rattus norvegicus) sprague dawley rats induced by haloperidol. J Farm Indones. 2017;14(2):160–8.
AlSaid M, Mothana R, Raish M, Al-Sohaibani M, Al-Yahya M, Ahmad A, et al. Evaluation of the effectiveness of Piper cubeba extract in the amelioration of CCl 4-induced liver injuries and oxidative damage in the rodent model. Biomed Res Int. 2015;2015:1–11.
Waku I, Magalhães MS, Alves CO, de Oliveira AR. Haloperidol-induced catalepsy as an animal model for parkinsonism: a systematic review of experimental studies. Eur J Neurosci. 2021;53(11):3743–67.
Duty S, Jenner P. Animal models of Parkinson’s disease: A source of novel treatments and clues to the cause of the disease. Br J Pharmacol. 2011;164(4):1357–91.
Khedir S Ben. Effects of minor components of olive oil on health. J Complement Med Altern Healthc. 2018;5(2):6–10.
Nord M. Levodopa pharmacokinetics - from stomach to brain: a study on patients with Parkinson’s disease. 2017;1–79 p.
Schirinzi T, Martella G, Imbriani P, Di Lazzaro G, Franco D, Colona VL, et al. Dietary vitamin E as a protective factor for Parkinson’s disease: clinical and experimental evidence. Front Neurol. 2019;10(February):1–7.
Bellettato CM, Scarpa M. Possible strategies to cross the blood–brain barrier. Ital J Pediatr. 2018;44(S2).
Pietta PG. Flavonoids as antioxidants. J Nat Prod. 2000;63(7):1035–42.
Ortiz GG, Pacheco-Moisés FP, Mireles-Ramírez MA, Flores-Alvarado LJ, González-Usigli H, Sánchez-López AL, et al. Oxidative stress and Parkinson’s disease: effects on environmental toxicology. Free Radicals Dis. 2016;
Filograna R, Beltramini M, Bubacco L, Bisaglia M. Anti-oxidants in Parkinson’s disease therapy: a critical point of view. Curr Neuropharmacol. 2016;14(3):260–71.











